[Shandong, China – Feb 3, 2026] – Mr. Zhao Mingjie, Chairman of Hebei Jingke Animal Pharmaceutical Co., Ltd. ("Jingke Pharma"), led a delegation to visit the Changle facility of Grand Pharma Life Sciences (Qingdao) Co., Ltd. (Shandong Yihao Biotechnology Co., Ltd., hereinafter "Yihao Biology"). The visit focused on technical R&D, optimization of 60m³ large-scale fermentation processes, and global market resource integration, aiming to create a new blueprint for collaborative growth in the animal health sector.

The delegation toured the production lines, focusing on Yihao Biology's animal feed probiotic fermentation workshops. With 60m³ and 50m³ fermentation tanks and a 3t/h spray drying system, Yihao Biology achieves an annual output of 3,000 tons of solid and 2,000 tons of liquid products. The rigorous quality control from strain cultivation to finished product traceability was highly commended.

During the symposium, CGE Chairman Zhao Yaoyao highlighted Yihao's leadership across animal, agricultural, food, and environmental microbial sectors. Backed by a high-caliber R&D team including Ph.D. experts, Yihao has filed 16 patents and achieved significant breakthroughs in disease control and growth-promoting microbial strains.

Chairman Zhao Mingjie of Jingke Pharma noted that Yihao's technical prowess perfectly complements Jingke's market resources. Both parties reached a consensus to collaborate on R&D for green animal health products, driving the high-quality transformation of the livestock industry.







